Advanced Micro Devices, Inc. posts record Q3 2025 results, surges in AI and data center markets, and eyes major growth ahead.

First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in ...

Dyne Therapeutics intends to submit a biologics licence application to the FDA for accelerated approval in Q2 2026.

"Future", China's first deep-sea green and intelligent technology experimental vessel, recently completed its first deep and remote sea test since its delivery in July this year. After six years of ...

As the world faces a surge of new synthetic chemicals and increasingly complex toxicity patterns, traditional animal testing ...

As 2025 winds down, companies and supply chain leaders are navigating a holiday season and business landscape that are ...

AIoT World's Carl Ford speaks with Novelis' Chirag Agrawal about AIoT and Agrawal's views on how AI is impacting Industry 4.0 ...

Evvy’s new UTI+ Test and microbiome tools deliver faster, clearer insights into BV and UTI care, reshaping women’s health ...

While all attention is paid to company-level security, vendor and business supplier side risks are often overlooked. Here is ...

Wave Life Sciences' $3.5B valuation reflects both pipeline risk and opportunity. Click here to find out why WVE stock is a ...

The AI hosts kept riffing on my diary, treating my teenage drama like it was some deep case study. Hearing that deep analysis style applied to pure melodrama was genuinely funny. Diary: I know she's ...

The Department of Health and Human Services has set up a plan for AI implementation across the agency that relies on five ...